937
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Mucosal-Associated Invariant T Cell Deficiency in Chronic Obstructive Pulmonary Disease

, , , , , , , , & show all

References

  • Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3(11):e442.
  • Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187(4):347–365.
  • Bruce N, Perez-Padilla R, Albalak R. Indoor air pollution in developing countries: a major environmental and public health challenge. Bull World Health Organ 2000; 78(9):1078–1092.
  • Rivera RM, Cosio MG, Ghezzo H, et al. Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. Int J Tuberc Lung Dis 2008; 12(8):972–977.
  • Le Bourhis L, Martin E, Peguillet I, et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 2010; 11(8):701–708.
  • Treiner E, Lantz O. CD1d- and MR1-restricted invariant T cells: of mice and men. Curr Opin Immunol 2006; 18(5):519–526.
  • Kee SJ, Park YW, Cho YN, et al. Age- and gender-related differences in circulating natural killer T cells and their subset levels in healthy Korean adults. Hum Immunol 2012; 73(10):1011–1016.
  • Lee OJ, Cho YN, Kee SJ, et al. Circulating mucosal-associated invariant T cell levels and their cytokine levels in healthy adults. Exp Gerontol 2014; 49:47–54.
  • Cho YN, Kee SJ, Kim TJ, et al. Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus. J Immunol 2014; 193(8):3891–3901.
  • Ussher JE, Klenerman P, Willberg CB. Mucosal-associated invariant T-cells: new players in anti-bacterial immunity. Front Immunol 2014; 5:450.
  • Kjer-Nielsen L, Patel O, Corbett AJ, et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 2012; 491(7426):717–723.
  • Patel O, Kjer-Nielsen L, Le Nours J, et al. Recognition of ­vitamin B metabolites by mucosal-associated invariant T cells. Nat Commun 2013; 4:2142.
  • Walker LJ, Kang YH, Smith MO, et al. Human MAIT and CD8alphaalpha cells develop from a pool of type-17 precommitted CD8+ T cells. Blood 2012; 119(2):422–433.
  • Dusseaux M, Martin E, Serriari N, et al. Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 2011; 117(4):1250–1259.
  • Le Bourhis L, Guerri L, Dusseaux M, et al. Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol 2011; 32(5):212–218.
  • Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009; 360(23):2445–2454.
  • Chi SY, Ban HJ, Kwon YS, et al. Invariant natural killer T cells in chronic obstructive pulmonary disease. Respirology 2012;17(3):486–492.
  • Paats MS, Bergen IM, Hoogsteden HC, et al. Systemic CD4+ and CD8+ T-cell cytokine profiles correlate with GOLD stage in stable COPD. Eur Respir J 2012; 40(2):330–337.
  • Martin E, Treiner E, Duban L, et al. Stepwise development of MAIT cells in mouse and human. PLoS Biol 2009; 7(3):e54.
  • Clinical and Laboratory Standards Institute (CLSI). User verification of precision and estimation of bias; approved guideline. 3rd ed. Wayne, PA, USA: CLSI; 2014. CLSI document EP15-A3.
  • Cosgrove C, Ussher JE, Rauch A, et al. Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection. Blood 2013; 121(6):951–961.
  • Jiang J, Wang X, An H, et al. Mucosal-associated invariant T-cell function is modulated by programmed death-1 signaling in patients with active tuberculosis. Am J Respir Crit Care Med 2014; 190(3):329–339.
  • Leeansyah E, Ganesh A, Quigley MF, et al. Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood 2013; 121(7):1124–1135.
  • Miyazaki Y, Miyake S, Chiba A, et al. T. Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. Int Immunol 2011; 23(9):529–535.
  • Serriari NE, Eoche M, Lamotte L, et al. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clin Exp Immunol. 2014; 176(2):266–274.
  • Jo J, Tan AT, Ussher JE, et al. Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver. PLoS Pathog 2014; 10(6):e1004210.
  • Ussher JE, Bilton M, Attwod E, et al. CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner. Eur J Immunol 2014; 44(1):195–203.
  • Thomsen M, Ingebrigtsen TS, Marott JL, et al. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA 2013; 309(22):2353–2361.
  • Makris D, Lazarou S, Alexandrakis M, et al. Tc2 response at the onset of COPD exacerbations. Chest 2008; 134(3):483–488.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.